EKF Diagnostics Holdings plc

EKF Diagnostics Holdings plc EKF

Dividend Summary


The previous EKF Diagnostics Holdings plc dividend was 1.2p and it went ex 1 year ago and it was paid 12 months ago.
There is typically 1 dividend per year (excluding specials), and the dividend cover is approximately 2.0.

Latest Dividends
Summary Previous dividend Next dividend
Status Paid
Type Final
Per share 1.2p
Declaration date 28 Mar 2023 (Tue)
Ex-div date 02 Nov 2023 (Thu)
Pay date 01 Dec 2023 (Fri)

Enter the number of EKF Diagnostics Holdings plc shares you hold and we'll calculate your dividend payments:

Previous Payment
Next Payment
Forecast Accuracy
95%
Our premium tools have predicted EKF Diagnostics Holdings plc with 95% accuracy.
Dividend Yield Today
0.0%
The dividend yield is calculated by dividing the annual dividend payment by the prevailing share price
The table below shows the full dividend history for EKF Diagnostics Holdings plc
Status Type Decl. date Ex-div date Pay date Decl. Currency Forecast amount Decl. amount Accuracy
Paid Final 28 Mar 2023 02 Nov 2023 01 Dec 2023 GBP 1.31p 1.2p 😊
Paid Final 29 Mar 2022 03 Nov 2022 01 Dec 2022 GBP 1.2p 1.2p 😄
Paid Final 30 Mar 2021 04 Nov 2021 01 Dec 2021 GBP 1.1p
Paid Final 15 Jul 2019 05 Nov 2020 01 Dec 2020 GBP 1p
Year Amount Change
2006 0.0p
2007 0.0p
0%
2008 0.0p
0%
2009 0.0p
0%
2010 0.0p
0%
2011 0.0p
0%
2012 0.0p
0%
2013 0.0p
0%
2014 0.0p
0%
2015 0.0p
0%
2016 0.0p
0%
2017 0.0p
0%
2018 0.0p
0%
2019 1.0p
100%
2020 1.1p
10.0%
2021 1.2p
9.1%
2022 1.2p
0%

EKF Diagnostics Holdings plc Optimized Dividend Chart

The chart below shows the optimized dividends for this security over a rolling 12-month period.
Dividend Yield Today
0.0%
Optimized Yield
Sign Up Required
52 Week High
6.6% on 08 August 2024
52 Week Low
0.0% on 17 September 2024
Next Ex-Div-Date Countdown
Sign Up Required

About EKF Diagnostics Holdings plc

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company's point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases. The Company's Central Laboratory division includes a range of products for use in both large and small laboratory facilities. Its subsidiary, EKF Life Sciences, provides bulk diagnostic enzyme manufacturing and fermentation services. EKF Life Sciences specializes in producing enzymes, including Salicylate Hydroxylase and Beta-Hydroxybutyrate Dehydrogenase. Its products include Quo-Test A1c, Biosen C-Line and Biosen S-Line, STAT-Site M B-HB analyzer, sTNFR1 biomarker test kits and Altair 240.

Sector
Health Care Equipment & Services
Country
United Kingdom
Share Price
£0.26 (yesterday's closing price)
Shares in Issue
455 million
Market Cap
£117mn
Dividend Cover
How many times is the dividend covered by company income. A cover of 1 means all income is paid out in dividends
2.0
CADI
The Consecutive Annual Dividend Increases - the number of years this company has been increasing its dividends
0
Market Indices
none